ID: ALA4459092

Max Phase: Preclinical

Molecular Formula: C29H37FO3

Molecular Weight: 452.61

Molecule Type: Unknown

Representations

Canonical SMILES:  CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)F)CC[C@]3(C)CC[C@]12C

Standard InChI:  InChI=1S/C29H37FO3/c1-17-18-7-8-21-27(4,19(18)15-20(31)23(17)32)12-14-29(6)22-16-26(3,24(30)33)10-9-25(22,2)11-13-28(21,29)5/h7-8,15,22,32H,9-14,16H2,1-6H3/t22-,25-,26-,27+,28-,29+/m1/s1

Standard InChI Key:  COVSAPDFNJBGKH-JJWQIEBTSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 452.61

Molecular Weight (Monoisotopic): 452.2727

AlogP: 7.11

#Rotatable Bonds: 1

Polar Surface Area: 54.37

Molecular Species: NEUTRAL

HBA: 3

HBD: 1

#RO5 Violations: 1

HBA (Lipinski): 3

HBD (Lipinski): 1

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 9.75

CX Basic pKa:

CX LogP: 5.58

CX LogD: 5.57

Aromatic Rings: 0

Heavy Atoms: 33

QED Weighted: 0.43

Np Likeness Score: 2.99

References

1. Chen Z, Zhang D, Yan S, Hu C, Huang Z, Li Z, Peng S, Li X, Zhu Y, Yu H, Lian B, Kang Q, Li M, Zeng Z, Zhang XK, Su Y..  (2019)  SAR study of celastrol analogs targeting Nur77-mediated inflammatory pathway.,  177  [PMID:31132532] [10.1016/j.ejmech.2019.05.009]

Source

Source(1):

• Scientific Literature